
cataliesw's Updates (71)
- 
                        When displayed on the surface of exosomes, these molecules show increased solubility/functionality and can be used for a wide range of applications, including drug discovery, ligand screening, and targeted drug delivery. Creative Biolabs utilizes this technology, termed exosome display, for different research purposes and to promote clinical applications. Learn more:Cancer vaccines consist of one or more antigenic components, including live-attenuated or killed viral or bacterial particles, proteins, polysaccharides, polynucleotides, and particle conjugates. Additionally, other excipients like adjuvants may be present. Not only the chemical and structural integrity of various components must be maintained, but the immunogenicity must be ensured. Thus, the complexity of vaccines creates a unique challenge for characterization. Learn more about GMP cancer...Mesenchymal stem cells (MSC) have received significant attention in recent years with regard to their suitability for use in cellular therapies due to their high growth potential and multipotential differentiation capacity. As a trusted research partner in the field of biotherapeutics, Creative Biolabs provides cutting-edge cell therapy research services covering every stage of MSC development, including isolation, expansion, characterization, and differentiation. Learn more about mesenchymal...Macrophages play an important role in cancer development and metastasis. Proinflammatory M1 macrophages can target cancerous cells, and therefore, can be engineered as drug carriers for tumor therapy. As a leading specialist in engineering macrophages, Creative Biolabs provides comprehensive R&D services of engineering M1 macrophages, macrophage-derived exosomes, and macrophage membrane as drug carriers. Learn more about Engineering Macrophage for Drug Delivery:SEEDbody represents a groundbreaking fusion protein built on the innovative Fc analogue platform, leveraging the strand-exchange engineered domain (SEED) technique. SEED is a humanized CH3 domain, comprising alternating segments of human IgG and IgA CH3 sequences, forming complementary heterodimers. Learn more about SEEDbody Generation: https://www.creative-biolabs.com/bsab/overview-of-seedbody.htmParticulate matter (PM), especially particulates with diameters of less than 2.5 mm, can penetrate the alveolar region and increase the risk of respiratory diseases. The proven adverse health effects of PM have stimulated various research efforts to develop methods for its detection. With years of research and development experience in phage display technology, Creative Biolabs has a group of scientists who are proficient in identifying binding-peptide with high specificity and affinity to...Immune checkpoints are regulators to enhance or moderate immune responses. Immune checkpoint mechanisms are often activated to suppress the nascent anti-tumor immune response, which leads to the development of several immune checkpoint inhibitors, such as antibodies, peptides, and small molecular drugs for cancer therapy. Learn more about ICI research:During years of exploration in neural differentiation models, Creative Biolabs has developed a comprehensive technology platform with a variety of available models. Our platform is now equipped with advanced facilities, experienced experts, and the latest technologies. With these strong foundations, we are confident in offering custom dopaminergic neurons differentiation model services to global clients. Learn more about ipsc derived dopaminergic neurons:Derived from early blastocyst embryos, human embryonic stem cells (hESC) are self-renewable cells with pluripotency. Under special culture conditions, neural cells can be generated from hESC including glial cells, functional neurons, and oligodendrocytes. To avoid other lineage cells as contaminants, the neural progenitor (NP) cell population is necessary to the neural lineage and has been served as an unlimited lineage-restricted cell source for therapeutic and research. Learn more about...A comprehensive study of neurogenesis allows scientists to better study numerous neurodegenerative disorders and for this purpose develop new therapies. As an expert in the field of neuroscience, Creative Biolabs is committed to providing innovative and professional neurogenesis assays to customers around the world. Learn more: https://neuros.creative-biolabs.com/neurogenesis-assay.htmAt Creative Biolabs, our pioneering advancements in the field of neurochemistry assays are at the forefront of neuroscience research. With over two decades of expertise in the industry, we have established ourselves as a leading provider of cutting-edge technology platforms and comprehensive assay solutions for neurochemistry research. Learn more about neurochemistry of a drug:High-throughput sequencing by whole genome or transcriptome amplification at single-cell level reveals the genetic structure and gene expression status of individual cells, reflecting intercellular heterogeneity. Single cell immune profiling is more suitable for solving a small number of special sample studies, heterogeneous population analysis, and the search for simultaneous or mutually exclusive genomic changes, which is limited by bulk analysis. Learn more about scTCR seq:The outbreak of a new coronavirus (SARS-CoV-2) is driving China’s urgent public health actions, as well as an international concern. Infection prevention and control through diagnostic testing and quarantine has become critical. Creative Biolabs offers an in vitro diagnostic (IVD) reagent development platform for improved detection and control of SARS-CoV-2. Learn more about IVD reagents SARS-CoV-2:The model organisms are non-human species, which are used to research biological processes, discoveries made in the organism model will provide insight into the workings of other organisms. Model organisms have become the irreplaceable tools of fundamental biological and clinical research and will help scientists to amass an enormous amount of knowledge.Learn more about anti species antibody:IgG molecules of the IgG1, IgG2, and IgG4 subclasses exhibit exceptionally long half-lives due to FcRn-mediated recycling. Half-lives of up to 4 weeks have been described for therapeutic antibodies. The binding site for FcRn resides in the Fc region is formed by the CH2 and CH3 domains. Learn more about Fc-Fusion Protein Development:




















